Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Ex-ArthroCare CFO gets four years in U.S. prison for fraud scheme

Published 01/05/2018, 04:09 PM
Updated 01/05/2018, 04:10 PM
© Reuters.  Ex-ArthroCare CFO gets four years in U.S. prison for fraud scheme
SN
-

By Nate Raymond

(Reuters) - The former chief financial officer of medical device company ArthroCare Corp was sentenced on Friday to more than four years in prison after pleading guilty to participating in what federal prosecutors called a $750 million securities fraud.

Michael Gluk, 59, was sentenced by U.S. District Judge Sam Sparks in Austin, Texas, after pleading guilty in June to one count of conspiracy to commit wire and securities fraud, the U.S. Justice Department said.

The sentencing came after Gluk in August testified at the trial of former ArthroCare Chief Executive Officer Michael Baker, who was convicted of securities fraud, wire fraud and other charges and sentenced in November to 20 years in prison.

Both men were convicted at a trial in 2014. But a federal appeals court in January 2016 overturned their convictions after finding that evidence was improperly excluded from the trial.

Gluk had been serving a prison sentence of 10 years when the appeals court overturned his conviction. He is expected, as part of his new sentence of 50 months in prison, to receive credit for the 13 months that his lawyers said he had already served.

Sparks ordered Gluk to pay a $50,000 fine and to forfeit $677,804, the Justice Department said. A lawyer for Gluk did not respond to a request for comment.

Prosecutors said Baker and Gluk, along with others, schemed from 2005 to 2009 to prop up ArthroCare's stock price by artificially inflating sales and revenue through a series of transactions with distributors.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Two other ex-ArthroCare executives, John Raffle and David Applegate, pleaded guilty to felonies in 2013 stemming from their involvement in the scheme. They were sentenced to prison terms of 80 months and 60 months.

ArthroCare agreed in January 2014 to pay a $30 million penalty and enter a deferred prosecution agreement to end a Justice Department probe.

The Austin-based company was acquired later that year by British medical equipment company Smith & Nephew Plc (L:SN) in a $1.7 billion deal.

The case is U.S. v. Baker, et al, U.S. District Court, Western District of Texas, No. 13-cr-346.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.